Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q1 2018 Results - Earnings Call Transcript [Seeking Alpha]
Cyclacel Pharmaceuticals, Inc. (CYCC)
Last cyclacel pharmaceuticals, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.cyclacel.com/investor-relations
Company Research
Source: Seeking Alpha
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) Q1 2018 Results Earnings Conference Call May 14, 2018 4:30 PM ET Executives Alexander Fudukidis - IR Spiro Rombotis - President and CEO Paul McBarron - EVP, Finance and Chief Operating Officer Judy Chiao - VP of Clinical Development and Regulatory Affairs Analysts Operator Good afternoon, and welcome to the Cyclacel Pharmaceuticals' First Quarter 2018 Results Conference Call and Webcast. Today's call is being recorded. [Operator Instructions] The company will be accepting a limited number of questions submitted via e-mail to the address ir@cyclacel.com. It is now my pleasure to turn the floor over to the company. Alexander Fudukidis Good afternoon, everyone, and thank you for joining the conference call to discuss Cyclacel's first quarter results and business highlights for the quarter ended March 31, 2018. Before turning the call over to management, I would like to remind everyone that during this conferen
Show less
Read more
Impact Snapshot
Event Time:
CYCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYCC alerts
High impacting Cyclacel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CYCC
News
- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial ResultsGlobeNewswire
- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target lowered by analysts at Roth Mkm from $21.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
- Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules [Yahoo! Finance]Yahoo! Finance
CYCC
Earnings
- 3/19/24 - Beat
CYCC
Sec Filings
- 5/8/24 - Form DEFA14A
- 5/8/24 - Form ARS
- 5/8/24 - Form DEF
- CYCC's page on the SEC website